San Clemente, CA – September 29, 2025 – Reflow Medical, Inc., a leading developer of innovative devices for treating complex cardiovascular disease, announces the completion of enrollment in the DEEPER…
Read More
Spur® Peripheral Retrievable Stent System Receives FDA De NovoClearance We’re proud to announce that our first-of-its-kind Spur Stent System is now commercially available in the U.S. Featuring innovative Spur technology,…
In the past 12 months, we’ve signed 25 new distribution agreements with strong, strategic partners located outside of the U.S. who understand our mission and are ready to amplify it….
San Clemente, CA – May 29, 2025 – Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug…
San Clemente, CA – March 6, 2025 – Reflow Medical, Inc., a leading developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary…
Global PAD Assn. Recognizes Reflow Medical CEO Isa Rizk John Phillips, MD talks about raising PAD awareness with the winner of the “Corporate Champion of Awareness” Award, our own Isa…
On November 5, 2024, the VIVA Foundation reported on presentations at the VIVA25 conference, including two-year results of the DEEPER OUS clinical trial for the Reflow Medical Spur® Peripheral Retrievable…
Updates on Spur® Retrievable Scaffold Therapy (RST) at AMP At the Amputation Prevention Symposium (AMP) held in Chicago in August, S. Jay Mathews, MD, provided an excellent review: “Retrievable Stent…
Enrollment Completed in the DEEPER REVEAL Clinical Trial We want to thank everyone who worked to complete enrollment in the DEEPER REVEAL clinical trial (NCT05358353) to evaluate Spur™ Retrievable Scaffold…
San Clemente, CA – July 1, 2024 – Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces the first patient enrollments in “A pilot study of…
Recent Comments